ADPT

ADPT CORP COM STK (DE)

ADPT

Overview Fund Activity

Delisted

ADPT was delisted on the 4th of August, 2010.

Back to rankings

Technology Communication Equipment

Financial journalist opinion

Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice

Does Adaptive Biotechnologies (ADPT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice

Zacks Investment Research

Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY.

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Zacks Investment Research

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?

Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts

Adaptive Biotechnologies and Netflix were top contributors, driven by strong earnings, momentum in core businesses, and positive outlooks. UnitedHealth Group and Visa detracted from performance due to earnings weakness, guidance cuts, and potential disruption from stablecoins. We initiated a position in HubSpot for its strong SMB positioning, AI-driven growth, and scalable financials, while exiting Expedia due to recession risks.

Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts

The Motley Fool

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday

Just after market close, Adaptive Biotechnologies (ADPT 5.97%) took the wraps off its second quarter. The following day, investors reacted to this by bidding the biotech company's stock up by almost 6%.

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday

The Motley Fool

Adaptive (ADPT) Q2 Revenue Surges 36%

Adaptive (ADPT) Q2 Revenue Surges 36%

Adaptive (ADPT) Q2 Revenue Surges 36%

Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript

Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Chad M. Robins - Co-Founder, CEO & Chairman Karina Calzadilla - Vice President of Investor Relations Kyle Piskel - VP, CFO & Principal Accounting Officer Susan Bobulsky - Chief Commercial Officer of MRD Conference Call Participants Andrew Frederick Brackmann - William Blair & Company L.L.C.

Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript

See News Rankings

Charts implemented using Lightweight Charts™